相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Identification of GSK-3 as a Potential Therapeutic Entry Point for Epilepsy
Najat Aourz et al.
ACS CHEMICAL NEUROSCIENCE (2019)
GSK3 beta activity alleviates epileptogenesis and limits GluA1 phosphorylation
Malgorzata Urbanska et al.
EBIOMEDICINE (2019)
An Overview on the Clinical Development of Tau-Based Therapeutics
Miguel Medina
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Tau-Induced Pathology in Epilepsy and Dementia: Notions from Patients and Animal Models
Marina P. Sanchez et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Prospects for strain-specific immunotherapy in Alzheimer's disease and tauopathies
Alice Bittar et al.
NPJ VACCINES (2018)
Novel Protein Kinase Inhibitors Related to Tau Pathology Modulate Tau Protein-Self Interaction Using a Luciferase Complementation Assay
Max Holzer et al.
MOLECULES (2018)
Bi-directional genetic modulation of GSK-3β exacerbates hippocampal neuropathology in experimental status epilepticus
Tobias Engel et al.
CELL DEATH & DISEASE (2018)
Ten Years of Tau-Targeted Immunotherapy: The Path Walked and the Roads Ahead
Petr Novak et al.
FRONTIERS IN NEUROSCIENCE (2018)
Designing of dual inhibitors for GSK-3β and CDK5: Virtual screening and in vitro biological activities study
Hongbo Xie et al.
ONCOTARGET (2017)
Axonal Degeneration in Tauopathies: Disease Relevance and Underlying Mechanisms
Andrew Kneynsberg et al.
FRONTIERS IN NEUROSCIENCE (2017)
Emergence of early alterations in network oscillations and functional connectivity in a tau seeding mouse model of Alzheimer's disease pathology
A. Ahnaou et al.
SCIENTIFIC REPORTS (2017)
Hyperphosphorylated tau in patients with refractory epilepsy correlates with cognitive decline: a study of temporal lobe resections
Xin You Tai et al.
BRAIN (2016)
New Features about Tau Function and Dysfunction
Miguel Medina et al.
BIOMOLECULES (2016)
Tau-Dependent Kv4.2 Depletion and Dendritic Hyperexcitability in a Mouse Model of Alzheimer's Disease
Alicia M. Hall et al.
JOURNAL OF NEUROSCIENCE (2015)
Tau Phosphorylation at Serine 396 Residue Is Required for Hippocampal LTD
Philip Regan et al.
JOURNAL OF NEUROSCIENCE (2015)
Critical role of acetylation in tau-mediated neurodegeneration and cognitive deficits
Sang-Won Min et al.
NATURE MEDICINE (2015)
The Role of Wnt/β-Catenin Signaling Pathway in Disrupted Hippocampal Neurogenesis of Temporal Lobe Epilepsy: A Potential Therapeutic Target?
Cheng Huang et al.
NEUROCHEMICAL RESEARCH (2015)
MOUSE HIPPOCAMPAL PHOSPHORYLATION FOOTPRINT INDUCED BY GENERALIZED SEIZURES: FOCUS ON ERK, mTORC1 AND Akt/GSK-3 PATHWAYS
Giuseppe Gangarossa et al.
NEUROSCIENCE (2015)
Activation of AKT/GSK3β pathway by TDZD-8 attenuates kainic acid induced neurodegeneration but not seizures in mice
Malay Bhowmik et al.
NEUROTOXICOLOGY (2015)
Cognitive impairment in epilepsy: the role of network abnormalities
Gregory L. Holmes
EPILEPTIC DISORDERS (2015)
Cognition and hippocampal synaptic plasticity in mice with a homozygous tau deletion
Tariq Ahmed et al.
NEUROBIOLOGY OF AGING (2014)
Microtubule-associated protein tau is essential for long-term depression in the hippocampus
Tetsuya Kimura et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2014)
Tau protein kinases: Involvement in Alzheimer's disease
Ludovic Martin et al.
AGEING RESEARCH REVIEWS (2013)
Progress and Developments in Tau Aggregation Inhibitors for Alzheimer Disease
Bruno Bulic et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Tau Loss Attenuates Neuronal Network Hyperexcitability in Mouse and Drosophila Genetic Models of Epilepsy
Jerrah K. Holth et al.
JOURNAL OF NEUROSCIENCE (2013)
Antisense Reduction of Tau in Adult Mice Protects against Seizures
Sarah L. DeVos et al.
JOURNAL OF NEUROSCIENCE (2013)
GWAS of Cerebrospinal Fluid Tau Levels Identifies Risk Variants for Alzheimer's Disease
Carlos Cruchaga et al.
NEURON (2013)
Inflammatory process in Alzheimer's Disease
Marco A. Meraz-Rios et al.
FRONTIERS IN INTEGRATIVE NEUROSCIENCE (2013)
Interaction of Endogenous Tau Protein with Synaptic Proteins Is Regulated by N-Methyl-D-aspartate Receptor-dependent Tau Phosphorylation
Siddhartha Mondragon-Rodriguez et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Lovastatin Modulates Glycogen Synthase Kinase-3β Pathway and Inhibits Mossy Fiber Sprouting after Pilocarpine-Induced Status Epilepticus
Chun-Yao Lee et al.
PLOS ONE (2012)
Seizures in Alzheimer Disease: Clinical and Epidemiological Data
Dionysios Pandis et al.
EPILEPSY CURRENTS (2012)
Neurofibrillary tangle pathology and Braak staging in chronic epilepsy in relation to traumatic brain injury and hippocampal sclerosis: a post-mortem study
Maria Thom et al.
BRAIN (2011)
Amyloid-β/Fyn-Induced Synaptic, Network, and Cognitive Impairments Depend on Tau Levels in Multiple Mouse Models of Alzheimer's Disease
Erik D. Roberson et al.
JOURNAL OF NEUROSCIENCE (2011)
Post-translational modifications of tau protein: Implications for Alzheimer's disease
Ludovic Martin et al.
NEUROCHEMISTRY INTERNATIONAL (2011)
Protective effects of lithium treatment for spatial memory deficits induced by tau hyperphosphorylation in splenectomized rats
Wen-Fei Tan et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2010)
Levetiracetam, lamotrigine, and phenobarbital in patients with epileptic seizures and Alzheimer's disease
Eduardo Cumbo et al.
EPILEPSY & BEHAVIOR (2010)
STROKE Predicting the risk of poststroke epilepsy-why and how?
Joseph Kwan
NATURE REVIEWS NEUROLOGY (2010)
Tau-knockout mice show reduced GSK3-induced hippocampal degeneration and learning deficits
Elena Gomez de Barreda et al.
NEUROBIOLOGY OF DISEASE (2010)
Kainic acid-induced seizures activate GSK-3β in the hippocampus of D2R-/- mice
Prem P. Tripathi et al.
NEUROREPORT (2010)
A novel GSK-3 beta inhibitor reduces Alzheimer's pathology and rescues neuronal loss in vivo
L. Sereno et al.
NEUROBIOLOGY OF DISEASE (2009)
Tau phosphorylation: the therapeutic challenge for neurodegenerative disease
Diane P. Hanger et al.
TRENDS IN MOLECULAR MEDICINE (2009)
Glycogen synthase kinase-3β, or a link between amyloid and tau pathology?
D. Muyllaert et al.
GENES BRAIN AND BEHAVIOR (2008)
The role of Wnt signaling in neuronal dysfunction in Alzheimer's Disease
Nibaldo C. Inestrosa et al.
MOLECULAR NEURODEGENERATION (2008)
Variation in MAPT is associated with cerebrospinal fluid tau levels in the presence of amyloid-beta deposition
John S. K. Kauwe et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Differential regulation of dynein and kinesin motor proteins by tau
Ram Dixit et al.
SCIENCE (2008)
The GSK3 hypothesis of Alzheimer's disease
Claudie Hooper et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Pathological tau tangles localize to focal cortical dysplasia in older patients
Arjune Sen et al.
EPILEPSIA (2007)
Reducing endogenous tau ameliorates amyloid β-induced deficits in an Alzheimer's disease mouse model
Erik D. Roberson et al.
SCIENCE (2007)
Induction of the wnt inhibitor, dickkopf-1, is associated with neurodegeneration related to temporal lobe epilepsy
Carla Letizia Busceti et al.
EPILEPSIA (2007)
UP inhibits LTD in the hippocampus via regulation of GSK3β
Stephane Peineau et al.
NEURON (2007)
The MAPT H1c risk haplotype is associated with increased expression of tau and especially of 4 repeat containing transcripts
Amanda J. Myers et al.
NEUROBIOLOGY OF DISEASE (2007)
Kainate induces AKT, ERK and cdk5/GSK3 beta pathway deregulation, phosphorylates tau protein in mouse hippocampus
N. Crespo-Biel et al.
NEUROCHEMISTRY INTERNATIONAL (2007)
Glycogen synthase kinase-3 (GSK3) in psychiatric diseases and therapeutic interventions
Richard S. Jope et al.
CURRENT DRUG TARGETS (2006)
Tau phosphorylation, aggregation, and cell toxicity
J. Avila et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2006)
Novel glycogen synthase kinase 3 and ubiquitination pathways in progressive myoclonus epilepsy
H Lohi et al.
HUMAN MOLECULAR GENETICS (2005)
Efficacy and cognitive side effects of tiagabine and topiramate in patients with epilepsy
N Fritz et al.
EPILEPSY & BEHAVIOR (2005)
Tau gene alternative splicing: expression patterns, regulation and modulation of function in normal brain and neurodegenerative diseases
A Andreadis
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2005)
Effect of divalproex sodium on behavioural and cognitive problems in elderly dementia
JM Meinhold et al.
DRUGS & AGING (2005)
Seizures and epilepsy after ischemic stroke
O Camilo et al.
STROKE (2004)
Glycogen synthase kinase-3β phosphorylates bax and promotes its mitochondrial localization during neuronal apoptosis
DA Linseman et al.
JOURNAL OF NEUROSCIENCE (2004)
Inhibitory phosphorylation of glycogen synthase kinase-3 (GSK-3) in response to lithium - Evidence for autoregulation of GSK-3
F Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Effects of gabapentin and carbamazepine on the EEG and cognition in healthy volunteers
MC Salinsky et al.
EPILEPSIA (2002)
Comparative cognitive effects of carbamazepine and gabapentin in healthy senior adults
R Martin et al.
EPILEPSIA (2001)
Neuropsychological effects of epilepsy and antiepileptic drugs
P Kwan et al.
LANCET (2001)
Tau phosphorylation at serine 396 and serine 404 by human recombinant tau protein kinase II inhibits tau's ability to promote microtubule assembly
DB Evans et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Tau protein isoforms, phosphorylation and role in neurodegenerative disorders
L Buée et al.
BRAIN RESEARCH REVIEWS (2000)
分享论文
